Are pediatric autoimmune diseases primarily genetic diseases?

Current Opinion in Rheumatology

Volumn 20, Issue 5, 2008, Pages 589-594

  Shaw, Elizabeth A ^a   Stevens, Anne M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Autoimmune; Genetics; Juvenile dermatomyositis; Kawasaki disease; Pediatric; Systemic lupus erythematosus

Indexed keywords

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHILDHOOD DISEASE; DERMATOMYOSITIS; ENVIRONMENTAL FACTOR; EPIGENETICS; EXTRACHROMOSOMAL INHERITANCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOME; HEREDITY; HUMAN; IMMUNOREGULATION; INHERITANCE; MICROCHIMERISM; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; CHILD; GENETICS; IMMUNOLOGY; RHEUMATIC DISEASE; RISK FACTOR;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RHEUMATIC DISEASES; RISK FACTORS;

EID: 55249087419     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328307f283     Document Type: Review

References (59)

1. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
2. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-21.
3. Müller-Hilke B, Mitchison NA. The role of HLA promoters in autoimmunity. Curr Pharm Des 2006; 12:3743-3752.
4. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204-210. GWAS performed in large number of European adults with SLE identified new susceptibility loci, which may also be important in pediatric disease.
5. Onouchi Y, Tamari M, Takahashi A, et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet 2007; 52:179-190.
6. Murray KJ, Moroldo MB, Donnelly P, et al. Age-specific effects of juvenile rheumatoid arthritis- associated HLA alleles. Arthritis Rheum 1999; 42:1843-1853.
7. Prahalad S. Genetics of juvenile idiopathic arthritis: an update. Curr Opin Rheumatol 2004; 16:588-594.
8. Phelan JD, Thompson SD. Genomic progress in pediatric arthritis: recent work and future goals. Curr Opin Rheumatol 2006; 18:482-489.
9. Duffy DL. Genetic determinants of diabetes are similarly associated with other immune-mediated diseases. Curr Opin Allergy Clin Immunol 2007;7:468-474.
10. Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40:35-42. Original work describing a new functional polymorphism of ITPKC, its role as a negative regulator of T-cell activation, and its relationship to Kawasaki disease susceptibility in Japanese and US patient populations. The results of the study have clinical applications; the identification of potentially IVIG-resistant patients (those found to have the itpkc-3 C allele) may direct the early use of different treatments.
11. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358:929-939.
12. Kallel-Sellami M, Baili-Klila L, Zerzeri Y, et al. Pediatric systemic lupus erythematosus with C1q deficiency. Ann N Y Acad Sci 2007; 1108:193-196. A case report of a pediatric patient with C1q deficiency and SLE with a thorough review of C1q clinical presentation, epidemiology, and immunologic findings.
13. Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000; 39:133-141.
14. Porter A, Nelson JL. Immunogenetics of rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. In: Oksenberg J, Brassat D, editors. Immunogenetics of autoimmune disease. Landes Bioscience and Springer Science + Business Media; 2006.
15. Huang JL, Shaw CK, Lee A, et al. HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 2001; 21:103-105.
16. Liphaus Bde L, Goldberg AC, Kiss MH, et al. Analysis of human leukocyte antigens class II-DR in Brazilian children and adolescents with systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo 2002; 57:277-282.
17. Baca V, Velazquez-Cruz R, Salas-Martinez G, et al. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun 2006; 7:693-695.
18. Reddy MV, Velazquez-Cruz R, Baca V, et al. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 2007; 121:721-727. Case-control analysis showing the strong presence of three IRF5 gene polymorphisms in Mexican patients with SLE. There was a higher association of these polymorphisms in the Mexican population with SLE than in Europeans; the authors suggest this may relate to the more aggressive disease course experienced by some Mexican patients.
19. Velazquez-Cruz R, Orozco L, Espinosa-Rosales F, et al. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 2007; 15:336-341. A case-control study which identified PDCD1.3A SNP as a risk factor for susceptibility in childhood-onset SLE in a Mexican population. An increased association was not found for a previously identified polymorphism associated with lupus nephritis.
20. Liao CH, Yao TC, Chung HT, et al. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 2004; 31:2062-2067.
21. Mamyrova G, O'Hanlon TP, Monroe JB, et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum 2006; 54:3979-3987.
22. Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71:543-553.
23. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189:111-121.
24. Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity. Auto-immunity 2007; 40:582-590.
25. Hinks A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford) 2006; 45:365-368.
26. Rieck M, Arechiga A, Onengut-Gumuscu S, et al. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007; 179:4704-4710.
27. Miceli-Richard C, Comets E, Loiseau P, et al. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 2007; 56:3989-3994.
28. Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 2007; 19:309-314.
29. Johansson M, Arlestig L, Moller B, et al. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005; 52:1665-1669.
30. Lockshin MD, Mary Kirkland Center for Lupus Research Consortium. Biology of the sex and age distribution of systemic lupus erythematosus. Arthritis Rheum 2007; 57:608-611.
31. Pluchinotta FR, Schiavo B, Vittadello F, et al. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2007; 16:550-555.
32. Hughes GC, Thomas S, Li C, et al. Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 2008; 180:2029-2033.
33. Lee YJ, Shin KS, Kang SW, et al. Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 2004; 63:1244-1249.
34. McClain MT, Poole BD, Bruner BF, et al. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum 2006; 54:360-368.
35. Tsao CY, Mendell JR, Kissel JT. Dermatomyositis in two siblings and a brief review of familial dermatomyositis. J Child Neurol 2002; 17:540-542.
36. Rider LG, Gurley RC, Pandey JP, et al. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum 1998; 41:710-719.
37. Reed AM, Stirling JD. Association of the HLA-DQA1 0501 allele in multiple racial groups with juvenile dermatomyositis. Human Immunol 1995; 44:131-135.
38. Wedderburn LR, McHugh NJ, Chinoy H, et al., Juvenile Dermatomyositis Research Group (JDRG). HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositisscleroderma overlap. Rheumatology (Oxford) 2007; 46:1786-1791. This study identifies significant associations between HLA class II haplotypes and autoantibody associations in Caucasian pediatric patients with JDM and JDM/SSc, demonstrating genetic and serologic differences between the groups.
39. Zanelli E, Breedveld FC, de Vries RR. HLA association with autoimmune disease: a failure to protect? Rheumatology (Oxford) 2000; 39:1060-1066.
40. Hoover ML, Marta RT. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scand J Immunol 1997; 45:193-202.
41. Molitor ML, Haynes LD, Jankowska-Gan E, et al. HLA class I noninherited maternal antigens in cord blood and breast milk. Hum Immunol 2004; 65:231-239.
42. Stevens AM. Do maternal cells trigger or perpetuate autoimmune diseases in children? Pediatr Rheumatol Online J 2007; 5:9. Maternal microchimerism is found in blood and tissues of patients with autoimmune disease. This review defines microchimerism, and describes mechanisms by which chimeric cells may contribute to autoimmunity.
43. Barrera P, Balsa A, Alves H, et al. Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe. European Consortium on Rheumatoid Arthritis Families. Arthritis Rheum 2000; 43:758-764.
44. Harney S, Newton J, Milicic A, et al. Noninherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 2003; 42:171-174.
45. Pani MA, Van Autreve J, Van der Auwera BJ, et al. Nontransmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 2002; 45:1340-1343.
46. Lambert AP, Gillespie KM, Bingley PJ, et al. -to: Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K. (2002) Nontransmitted maternal HLA DQ2 or DQ8 alleles and risk of Type 1 diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340-1343. Diabetologia 2003; 46:590-591.
47. Reed AM, Picornell YJ, Harwood A, et al. Chimerism in children with juvenile dermatomyositis. Lancet 2000; 356:2156-2157.
48. Reed AM, McNallan K, Wettstein P, et al. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004; 172:5041-5046.
49. Artlett CM, Ramos R, Jiminez SA, et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 2000; 356:2155-2156.
50. Stevens AM, Hermes HM, Rutledge JC, et al. Myocardial-tissue- specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003; 362:1617-1623.
51. Suskind DL, Rosenthal P, Heyman MB, et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol 2004; 4:14.
52. Nelson JL, Gillespie KM, Lambert NC, et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007; 104:1637-1642.
53. Venkitaramani DV, Lombroso PJ. Molecular basis of genetic neuropsychiatric disorders. Child Adolesc Psychiatr Clin N Am 2007; 16:541-556.
54. Vadheim CM, Rotter JI, Maclaren NK, et al. Preferential transmission of diabetic alleles within the HLA gene complex. NEJM 1986; 315:1314-1318.
55. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998; 19:352-357.
56. Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol 2006; 176:7143-7147.
57. Migeon BR. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA 2006; 295:1428-1433.
58. Lu Q, Wu A, Tesmer L, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179:6352-6358. Elegant study suggesting that sex-specific DNA demethylation of an immunoregulatory locus in T cells contributes to SLE pathogenesis in adult females. This work opens a whole new field - the dysregulation of immunoregulatory genes on the inactive X chromosome in females - which may explain the female predominance of autoimmunity.
59. Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol 2007; 7:851-861.